Company news

PrJsC "Indar" in cooperation with the Swiss company, have developed new pen injector for insulin id Pen

PrJsC "Indar" in cooperation with the Swiss company, have developed new pen injector for insulin id Pen, which is characterized by high accuracy and ease of use.

Taking into account the needs and habits of Ukrainian patients, as well as global trends in medical technologies development, Ukrainian company "Indar" in cooperation with Swiss company «YPSOMED AG» developed pen injector for insulin id Pen for intensified conventional or conventional diabetes therapy for patients with type I or II diabetes mellitus. id Pen designed specifically for insulins, manufactured by "Indar".

Pen injector for insulin id Pen is user-friendly and intuitive, it has a range of specific advantages:

• Ability to administer insulin at a dose from 1 to 60 international units (IU) per injection
• Easy to dial and adjust the dose
• Large numbers on the dose display for good readability even for visually impaired patients
• Audible and tactile feedback - one IU corresponds to one-click
• Quick and easy changing of the cartridge
• Post-injection remaining dose controller which ensures correct dose of the drug, even if drug in the cartridge came to an end during injection